Sort
30,917 grants matching “tumor microenvironment”
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$610,563Carol Ann Lange · University Of Minnesota · R01 · FY2020 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$610,531Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2023 · CA
Imaging of Stromal Cells in the Tumor Microenvironment
$610,511Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2009 · CA
Molecular Pathology of Cancer
$610,480Michael Emmert-Buck · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
An automated high-throughput tissue model for screening metastatic effectors
$610,473David J Beebe · University Of Wisconsin-Madison · R01 · FY2015 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$610,423Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment
$610,415Sun Yang · Chapman University · R01 · FY2025 · CA
Simultaneous Microwave and MR Imaging for Improved Diagnosis of Breast Abnormalities
$610,382Keith D. Paulsen · Dartmouth College · R01 · FY2021 · CA
Multi-receptor Targeting of Glioblastoma
$610,326Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2022 · CA
The use of chitosan for cancer vaccine delivery
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$610,279Katerina Abigail Politi · Yale University · R01 · FY2015 · CA
Stress, the Immune System and Basal Cell Carcinoma
$610,218Ronald Glaser · Ohio State University · R01 · FY2006 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Therapeutic implication of CD38 in CLL
$610,213Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$610,097Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2025 · NS
A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment
$610,090Michalakis Averkiou · University Of Washington · R01 · FY2022 · EB
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies
$610,088Yuanpei Li · University Of California At Davis · R01 · FY2022 · EB
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
$610,087Chin-Tu Chen · University Of Chicago · R01 · FY2023 · CA
Immune Impact on Cancer Chemoresistance
$609,903Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Immunotherapy Strategies for Uveal Melanoma
$609,879Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$609,743Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Determining the impact of stromal cell-mediated type I IFN signaling on alphavirus pathogenesis
$609,702Deborah J Lenschow · Washington University · R01 · FY2025 · AI
Regulating the glioma immune microenvironment
$609,700Joanna Phillips · University Of California, San Francisco · R01 · FY2025 · NS
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
$609,551Dorothy Teegarden · Purdue University · R01 · FY2024 · CA